Using a new drug to protect knee cartilage from damage
Application of SHP2 PROTAC to Mitigate Articular Cartilage Degeneration
This study is looking at how a new drug called SHP2 PROTAC might help protect knee cartilage by focusing on important proteins that keep it healthy, and it could lead to better treatments for people with joint issues.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rhode Island Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project ID | NIH-10692898 on NIH RePORTER |
What this research studies
This research investigates how a drug called SHP2 PROTAC can help prevent damage to knee cartilage by targeting specific proteins involved in cartilage health. The study aims to understand the role of SHP2 in regulating a protein called SOX9, which is crucial for cartilage maintenance. By exploring how SHP2 depletion affects SOX9 levels and activity, the researchers hope to find new ways to promote cartilage repair and prevent degeneration. Patients may benefit from insights gained in this study that could lead to improved treatments for joint health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing knee joint issues or cartilage degeneration.
Not a fit: Patients with intact cartilage and no joint issues may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that protect and repair knee cartilage, improving joint function and reducing pain for patients.
How similar studies have performed: While the specific approach using SHP2 PROTAC is novel, similar strategies targeting cartilage health have shown promise in other research.
Where this research is happening
Providence, United States
- Rhode Island Hospital — Providence, United States (Active)
Researchers
- Principal investigator: Yang, Wentian — Rhode Island Hospital
- Study coordinator: Yang, Wentian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.